Intranasal submucosal bevacizumab for epistaxis in hereditary hemorrhagic telangiectasia: A double‐blind, randomized, placebo‐controlled trial

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0347|37|6|783-787

ISSN: 1043-3074

Source: HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol.37, Iss.6, 2015-06, pp. : 783-787

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract